Pharmaids Pharmaceuticals Ltd Announces Q3 and Nine Months Results for 2025

Pharmaids Pharmaceuticals Ltd, a prominent player in the pharmaceutical industry, has announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The company's revenue from operations stands at 83.28 Lacs for the quarter and 596.55 Lacs for the nine months ended period. The total income for the quarter is 89.37 Lacs and 615.61 Lacs for the nine months ended period. The company's expenses for the quarter are 13.12 Lacs and 1,162.05 Lacs for the nine months ended period. The profit before tax for the quarter is negative (423.75) Lacs and negative (233.38) Lacs for the nine months ended period. The total tax expense for the quarter is negative (112.77) Lacs and negative (68.15) Lacs for the nine months ended period. The profit for the year is negative (310.98) Lacs and negative (165.23) Lacs for the nine months ended period. The earnings per equity share (basic and diluted) for the year are Rs. (0.88) and Rs. (0.47) respectively.